FR2781225B1 - 1,4-dihydropyridines a groupe carbonyl pyridine - Google Patents

1,4-dihydropyridines a groupe carbonyl pyridine

Info

Publication number
FR2781225B1
FR2781225B1 FR9809165A FR9809165A FR2781225B1 FR 2781225 B1 FR2781225 B1 FR 2781225B1 FR 9809165 A FR9809165 A FR 9809165A FR 9809165 A FR9809165 A FR 9809165A FR 2781225 B1 FR2781225 B1 FR 2781225B1
Authority
FR
France
Prior art keywords
dihydropyridines
pyridine group
carbonyl pyridine
carbonyl
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9809165A
Other languages
English (en)
Other versions
FR2781225A1 (fr
Inventor
Gerard Duret
Gerard Glauert
Andre Pessonnier
Marguerite Henry
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cephalon France SAS
Original Assignee
Laboratoire L Lafon SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire L Lafon SA filed Critical Laboratoire L Lafon SA
Priority to FR9809165A priority Critical patent/FR2781225B1/fr
Priority to AU47898/99A priority patent/AU4789899A/en
Priority to PCT/FR1999/001748 priority patent/WO2000003712A1/fr
Publication of FR2781225A1 publication Critical patent/FR2781225A1/fr
Application granted granted Critical
Publication of FR2781225B1 publication Critical patent/FR2781225B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR9809165A 1998-07-17 1998-07-17 1,4-dihydropyridines a groupe carbonyl pyridine Expired - Fee Related FR2781225B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR9809165A FR2781225B1 (fr) 1998-07-17 1998-07-17 1,4-dihydropyridines a groupe carbonyl pyridine
AU47898/99A AU4789899A (en) 1998-07-17 1999-07-16 1-4-dihydropyridines with pyridinyl group as calcium blockers
PCT/FR1999/001748 WO2000003712A1 (fr) 1998-07-17 1999-07-16 1-4-dihydropyridines a groupe pyridinyle comme inhibiteurs calciques

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9809165A FR2781225B1 (fr) 1998-07-17 1998-07-17 1,4-dihydropyridines a groupe carbonyl pyridine

Publications (2)

Publication Number Publication Date
FR2781225A1 FR2781225A1 (fr) 2000-01-21
FR2781225B1 true FR2781225B1 (fr) 2000-10-06

Family

ID=9528731

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9809165A Expired - Fee Related FR2781225B1 (fr) 1998-07-17 1998-07-17 1,4-dihydropyridines a groupe carbonyl pyridine

Country Status (3)

Country Link
AU (1) AU4789899A (fr)
FR (1) FR2781225B1 (fr)
WO (1) WO2000003712A1 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2671349B1 (fr) * 1991-01-09 1993-04-23 Lafon Labor Nouveaux derives de 1,4-dihydropyridine, leur procede de preparation et composition therapeutique les contenant.
US5580871A (en) * 1992-11-20 1996-12-03 The Dupont Merck Pharmaceutical Company 4-Heteroaryl- 1,4-dihydropyridine compounds with calcium agonist and alpha1 -antagonist activity

Also Published As

Publication number Publication date
FR2781225A1 (fr) 2000-01-21
WO2000003712A1 (fr) 2000-01-27
AU4789899A (en) 2000-02-07

Similar Documents

Publication Publication Date Title
ID29241A (id) Turunan-turunan kinolin teranelasi-1,2
DE69933287D1 (de) 12,13-modifizierte epothilon-derivate
DZ2261A1 (fr) Cyclo-alcane pyridines.
NO2006016I1 (no) 7,8,9,10-tetrahydro-6H-6,10-metanoazepinoÄ4,5-gÜkinoksalintartrat
ATE275151T1 (de) 3,6-ketal-makrolidantibiotika
DE69821009D1 (de) 6,9-verbrückte erythromycin-derivate
NO20002099D0 (no) 6,11-bro-erytromycinderivater
NO990859D0 (no) 1,2,3,4-tetrahydro-benzofuro[3,2-c]pyridinderivater
ID26909A (id) Turunan-turunan 1,3,4-oksadiazolon
DE60025958D1 (de) 14,15-beta-methylen substituierte androgene
IT1299338B1 (it) Struttura componibile.
DK1149106T3 (da) 4,5-azolo-oxindoler
FR2781225B1 (fr) 1,4-dihydropyridines a groupe carbonyl pyridine
FR2781226B1 (fr) 1,4-dihydropyridines a groupe carbonyl benzodioxo
ID26368A (id) Turunan-turunan 2 deoksi higromisin
DK1068200T3 (da) 2,4,4-trisubstituerede-1,3-dioxolanfungicider
ID24047A (id) Turunan 5-tersubstitusi-3-oksaziazolil 1,6-naftiridin-2 1h-on
FR2781224B1 (fr) 1,4-dihydropyridines a groupe sulfonamide
ES1039434Y (es) Estanteria.
DE59508591D1 (de) 2-arylcyclopentan-1,3-dion-derivate
ES1037533Y (es) Estructura modular simple.
ES1035336Y (es) Paramento expositor modular.
ES1039480Y (es) Expositor modular perfeccionado.
IT244821Y1 (it) Struttura componibile .
FI914474A0 (fi) Runt gaoende reklamtavla.

Legal Events

Date Code Title Description
ST Notification of lapse